According to a recent market analysis by Future Market Insights (FMI), the Protein A Resins Market Demand will exceed US$ 1.2 billion by 2031 at an 8.1% CAGR.
Monoclonal antibody research and the development of biosimilar drugs will drive the demand for protein A resins. Monoclonal antibody research is being fueled by the global need for advanced and precise biosimilars to reduce cancer risk.
Download a Sample Copy of report to gain comprehensive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1720
Protein A resins are in high demand in contract manufacturing organisations, according to FMI (CMO). Favorable research initiatives and funding in CMOs for monoclonal antibody production will drive market growth.
As the development of monoclonal antibodies for virus treatment increased, the COVID-19 outbreak accelerated the sale of protein A resins. Aside from that, demand for natural protein A resins used in the purification of monoclonal antibodies increased during the FQ-20.
Natural protein A resins are becoming more popular in advanced research because they reduce ligand leaching and provide greater stability than traditional protein A resins. As a result, demand for natural protein A resins in biopharmaceutical manufacturing firms is expected to increase during the forecast period.
Protein A resin sales for antibody purification, according to FMI, will account for the majority of the market during the forecast period. The rising prevalence of cancer and other chronic diseases has increased the demand for therapeutic monoclonal antibodies.
As a result, biopharmaceutical companies are actively seeking strategic alliances and mergers with other key players in order to launch new products and therapeutic drugs while maintaining a competitive advantage in the industry.
“Steered by increasing demand for biosimilar and monoclonal antibodies for therapeutic use, biopharmaceutical manufacturing companies are increasing investments in research and development activities to push biologics production. This is expected to create lucrative growth opportunities for market players,” says an FMI analyst.
Avail Discount on Report@ https://www.futuremarketinsights.com/request-discount/rep-gb-1720
Key Takeaways:
- The United States is expected to dominate the North American protein A resins market, accounting for more than 93.5% of the market.
- Because of the growing number of biopharmaceutical companies focusing on the development of biosimilar drugs, the United Kingdom will account for nearly 24.1% of the European market.
- Because of the increasing use of biomaterials in drug research, China is expected to grow at a 9.8% CAGR in East Asia. Sales of protein A resins in Japan are expected to grow at a 7.8% CAGR during the forecast period.
- In terms of matrix type, agarose-based matrix of protein A resins will account for more than 85.8% of the market in 2021.
- Biopharmaceutical manufacturers are expected to be the primary end-users in 2021, accounting for 79.2% of the market.
Prominent Drivers:
- Growing demand for therapeutic antibodies, as well as extensive research into monoclonal antibodies, will drive the market forward.
- The rising prevalence of cancer has prompted medical professionals to conduct extensive research into the development of monoclonal antibodies for therapeutic use. This is driving the market’s demand.
Key Restraints:
- The high cost of resins and a scarcity of skilled research analysts are expected to limit protein growth. A market for resins
Competitive Landscape
Key players are collaborating with end users and other regional players to strengthen their global presence. Some of the market players are focusing on product launches to capitalize on growing demand for monoclonal antibodies from biopharmaceutical companies. For instance:
- Purolite, a global manufacturer of resin-based chromatography separation, purification, and extraction technologies, will commercialise two novel next-generation chromatography resins in September 2021.
- Avantor Inc., a global provider of mission-critical products and services to life-sciences customers, announced PROchievA, a new recombinant Protein A affinity chromatography resin used to purify antibodies during mAb production, in March 2020.
Request for Customized Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-1720
Leading players operating in protein A resins market profiled by FMI include:
- GE Healthcare
- Thermo Fisher Scientific
- Kaneka Corporation,
- JNC Corporation
- Purolite Life Sciences
- Bio-Rad Laboratories, Inc.
- JSR Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh Bioscience, Merck Group (Merck Millipore)
- Novasep Holdings SAS, Agilent Technologies, Inc.
- GenScript, Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio, PerkinElmer, Inc.
- Suzhou Nanomicro Technology Co., Ltd
- Others
More Insights on FMI’s Protein A Resins Market
The latest market study on the protein A resins market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to offer a better perspective of the global protein A resins market, its growth trajectory, trends, and opportunities, the market is segmented on the basis of:
By Product:
- Natural Protein A Resin
- Recombinant Protein A Resin
By Matrix:
- Agarose Based Matrix
- Glass or Silica Based Matrix
- Organic Polymer Based Matrix
By Application:
- Immunoprecipitation
- Antibody Purification
By End-User:
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
Key Questions Covered in Protein A Resins Market Report
- The report offers detailed insights into protein A resins market demand outlook for 2021-2031.
- The market study also highlights projected sales growth for protein A resins market between 2021 and 2031.
- Protein A resins market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry.
- Protein A resins market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
